{
    "code": "02025765",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025765",
    "time": "2016-11-18 20:44:47",
    "許可證字號": "衛署藥輸字第025765號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "106\/07\/20",
    "發證日期": "101\/07\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202576508",
    "中文品名": "怡瑞納&quot;山德士&quot;20毫克\/毫升注射液",
    "英文品名": "Irinotecan Sandoz 20mg\/ml concentrate for solution for infusion",
    "適應症": "晚期性大腸直腸癌之第一線治療藥物：與5-FU及folinic acid合併，使用於未曾接受過化學治療之患者。單獨使用於曾接受5-FU療程治療無效之患者。與cetuximab併用，治療曾接受含irinotecan之細胞毒性療法治療失敗且具有上皮生長因子接受體(EGFR)表現型KRAS野生型轉移性大腸直腸癌患者。與5-fluorouracol、folinic acid及bevacizumab合併治療，作為轉移性大腸癌或直腸癌患者的第一線治療藥物。與capecitabine合併治療，作為轉移性大腸直腸癌患者的第一線治療藥物。",
    "劑型": "270注射劑",
    "包裝": "100支以下盒裝 2、5、7.5、15、25毫升玻璃小瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "IRINOTECANHYDROCHLORIDETRIHYDRATE"
    ],
    "限制項目": "02輸　入 1Q不得輸入 24監視期滿學名藥",
    "申請商名稱": "1309306200  台灣諾華股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F030024000  EBEWE PHARMA GES.M.B.H.NFG. KG",
        "製造廠廠址": "MONDSEESTRABE 11,AT-4866 UNTERACH AM ATTERSEE, AUSTRIA",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200037710",
            "成分名稱": "IRINOTECAN HYDROCHLORIDE TRIHYDRATE",
            "含量描述": "(corr. To 18.4mg irinotecan hydrochlorid",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "怡瑞納仿單-105-03-08.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025765&Seq=002&Type=9"
        },
        {
            "title": "1011029 怡瑞納仿單(核定)___20121106.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025765&Seq=001&Type=9"
        },
        {
            "title": "怡瑞納7.5ml標籤-105-03-08.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025765&Seq=011&Type=8"
        },
        {
            "title": "怡瑞納7.5ml外盒-105-03-08.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025765&Seq=010&Type=8"
        },
        {
            "title": "Irinotecan_SZ_500MG_25ML_label___20121106.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025765&Seq=009&Type=8"
        },
        {
            "title": "Irinotecan_SZ_500MG_25ML_carton___20121106.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025765&Seq=008&Type=8"
        },
        {
            "title": "Irinotecan_SZ_40MG_2ML_label___20121106.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025765&Seq=007&Type=8"
        },
        {
            "title": "Irinotecan_SZ_40MG_2ML_carton___20121106.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025765&Seq=006&Type=8"
        },
        {
            "title": "Irinotecan_SZ_300MG_15ML_label___20121106.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025765&Seq=005&Type=8"
        },
        {
            "title": "Irinotecan_SZ_300MG_15ML_carton___20121106.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025765&Seq=004&Type=8"
        },
        {
            "title": "Irinotecan_SZ_100MG_5ML_label___20121106.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025765&Seq=003&Type=8"
        },
        {
            "title": "Irinotecan_SZ_100MG_5ML_carton___20121106.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025765&Seq=002&Type=8"
        },
        {
            "title": "Irinotecan Sandoz Chinese Label___20121106.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025765&Seq=001&Type=8"
        }
    ]
}